Publicacións en colaboración con investigadores/as de Universidad de Alcalá (9)

2024

  1. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

2018

  1. Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017

    PLoS ONE, Vol. 13, Núm. 10

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2008

  1. Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status

    International Journal of Tuberculosis and Lung Disease, Vol. 12, Núm. 12, pp. 1393-1400

2006

  1. Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature

    Human Pathology, Vol. 37, Núm. 10, pp. 1344-1349

  2. Viral kinetics and early prediction of nonresponse to peg-IFN-α-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus

    Journal of Viral Hepatitis, Vol. 13, Núm. 7, pp. 466-473

2005

  1. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804

2004

  1. High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin

    Antiviral Therapy, Vol. 9, Núm. 1, pp. 133-138